GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Other Long Term Assets

Steminent Biotherapeutics (ROCO:7729) Other Long Term Assets : NT$23.34 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics Other Long Term Assets?

Steminent Biotherapeutics's other long-term assets for the quarter that ended in Jun. 2024 was NT$23.34 Mil.

Steminent Biotherapeutics's quarterly other long-term assets increased from Jun. 2023 (NT$15.58 Mil) to Dec. 2023 (NT$19.80 Mil) and increased from Dec. 2023 (NT$19.80 Mil) to Jun. 2024 (NT$23.34 Mil).

Steminent Biotherapeutics's annual other long-term assets increased from Dec. 2021 (NT$13.66 Mil) to Dec. 2022 (NT$15.02 Mil) and increased from Dec. 2022 (NT$15.02 Mil) to Dec. 2023 (NT$19.80 Mil).

Steminent Biotherapeutics Other Long Term Assets Historical Data

The historical data trend for Steminent Biotherapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics Other Long Term Assets Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
12.82 13.66 15.02 19.80

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Long Term Assets Get a 7-Day Free Trial - 15.02 15.58 19.80 23.34

Steminent Biotherapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Steminent Biotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Other Long Term Assets
Comparable Companies
ROCO:6850 ROCO:6814 ROCO:4131 ROCO:6236 ROCO:6709 ROCO:4192 ROCO:6610 ROCO:4195 ROCO:7725 ROCO:4186 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Website
http://www.steminent.com
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines